These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 8446920)

  • 1. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF; Neumeyer JL; Waszczak BL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
    Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of SCH 23390 on the apomorphine subsensitivity in the substantia nigra and ventral tegmental area 1 day following withdrawal from continuous or intermittent cocaine pretreatment.
    Lee TH; Gao WY; Ellinwood EH
    Brain Res; 1997 Jan; 744(2):293-301. PubMed ID: 9027389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (-)-stepholidine on firing activity of dopamine neurons in ventral tegmental area of rats.
    Sun BC; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):395-9. PubMed ID: 1300038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.
    Mnie-Filali O; Dahan L; Zimmer L; Haddjeri N
    Eur J Pharmacol; 2007 Sep; 570(1-3):72-6. PubMed ID: 17586491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
    Kelland MD; Zhang J; Chiodo LA; Freeman AS
    Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion.
    Crawley JN
    Synapse; 1989; 3(4):346-55. PubMed ID: 2740993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.